CompletedPhase 2

A Randomized Study of Autologous Umbilical Cord Blood Reinfusion in Children With Cerebral Palsy

United States63 participantsStarted 2010-06

Plain-language summary

The purpose of this study is to determine the efficacy of a single intravenous infusion of autologous umbilical cord blood (UCB) for the treatment of pediatric patients with spastic cerebral palsy.

Who can participate

Age range12 Months – 6 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Total nuclear cell dose \< 1 x 107 cells/kilogram
✕. Positive maternal infectious disease markers (except CMV)
✕. Evidence of infectious contamination of the cord blood unit
✕. Lack of a test sample to confirm identity
✕. Evidence of a genetic disease

What they're measuring

Change in Gross Motor Function Measure 66 (GMFM-66) Score

Timeframe: Baseline to Year 1

Trial details

NCT IDNCT01147653

SponsorJoanne Kurtzberg, MD

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2016-03

Results submitted2017-03-15

View on ClinicalTrials.gov More Cerebral Palsy trials